The estimated Net Worth of Paul S Weiner is at least $1.46 million dollars as of 15 October 2019. Paul Weiner owns over 817 units of Conformis stock worth over $1,245,859 and over the last 9 years Paul sold CFMS stock worth over $212,772.
Paul has made over 14 trades of the Conformis stock since 2016, according to the Form 4 filled with the SEC. Most recently Paul sold 817 units of CFMS stock worth $1,748 on 15 October 2019.
The largest trade Paul's ever made was selling 17,723 units of Conformis stock on 18 October 2017 worth over $56,182. On average, Paul trades about 3,215 units every 50 days since 2015. As of 15 October 2019 Paul still owns at least 551,265 units of Conformis stock.
You can see the complete history of Paul Weiner stock trades at the bottom of the page.
Paul's mailing address filed with the SEC is C/O CONFORMIS, INC., 600 TECHNOLOGY PARK DRIVE, BILLERICA, MA, 01821.
Over the last 9 years, insiders at Conformis have traded over $10,769,806 worth of Conformis stock and bought 583,200 units worth $267,840 . The most active insiders traders include Capital Management Llcchris..., Philipp Lang et Mark A Augusti. On average, Conformis executives and independent directors trade stock every 21 days with the average trade being worth of $122,083. The most recent stock trade was executed by Mark A Augusti on 7 May 2022, trading 22,396 units of CFMS stock currently worth $10,302.
our mission patients vary in more ways than gender, race, and size. at conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. we start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. our implants are individually sized and shaped to fit to each patient’s unique anatomy, providing precise anatomic fit and preserving healthy tissue. our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. by combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient’s joint and minimizes surgical trauma. our company conformis, inc. is a privately h
Conformis executives and other stock owners filed with the SEC include: